7 FDA Food Recalls Everyone’s Talking About—What’s Pulled From Shelves
Stay informed on the latest food recalls—from mac & cheese bites to ground beef. Learn what’s affected and how to protect ...
Healthline2d
7 Food Allergy Mistakes It’s Easy to Make
Food allergies occur when your body reacts to a food particle as if it were harmful. Even when you’re aware of a food allergy ...
Muffin recall update as FDA issues highest risk warning
Muffins which were recalled in February have been issued the FDA's highest risk warning due to them having an undeclared allergen.
Injectable asthma drug resolves dangerous food allergies in one-third of children
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Rolling Out4d
New drug outperforms therapy for severe food allergies
Clinical trial shows omalizumab (Xolair) treats multiple severe food allergies more effectively than oral immunotherapy, with ...
Food Allergy Cure? This FDA-Approved Drug Helps Kids Eat Peanuts, Milk, And More!
A new clinical trial reveals that the asthma drug omalizumab (Xolair) helps food-allergic children eat trigger foods safely.
News-Medical.Net on MSN1d
How to manage allergies in children
For most children, symptoms may be controlled by avoiding the allergen, if known, and using nonprescription medicines. But if a child's symptoms are persistent and not relieved by nonprescription ...
BioSpace11d
First Head-to-Head Study Cements Roche’s Xolair as Food Allergy Leader
Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children ...
U.S. News & World Report11d
Injectable Drug Resolves Dangerous Food Allergies In One-Third Of Kids
Injectable Drug Resolves Dangerous Food Allergies In One-Third Of Kids By Dennis Thompson HealthDay Reporter MONDAY, March 3, 2025 (HealthDay News) -- More than a third of food-allergic kids were ...
Tyler Morning Telegraph12d
Injectable Drug Resolves Dangerous Food Allergies In One-Third Of Kids
And based on early results from this clinical trial, the FDA approved omalizumab as a treatment for food allergies in adults and children as young as 1 year old, researchers said in background notes.